Chen X, Wang Y, Shen HY, Wu R, Fu Z. Development and internal validation of an immune-based prognostic modeling of early-onset colorectal cancer via machine learning. World J Clin Oncol 2026; 17(1): 114238 [PMID: 41608336 DOI: 10.5306/wjco.v17.i1.114238]
Corresponding Author of This Article
Zan Fu, MD, Professor, Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, No. 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. fuzan1971@njmu.edu.cn
Research Domain of This Article
Immunology
Article-Type of This Article
Retrospective Cohort Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Jan 24, 2026 (publication date) through Feb 18, 2026
Times Cited of This Article
Times Cited (0)
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Share the Article
Chen X, Wang Y, Shen HY, Wu R, Fu Z. Development and internal validation of an immune-based prognostic modeling of early-onset colorectal cancer via machine learning. World J Clin Oncol 2026; 17(1): 114238 [PMID: 41608336 DOI: 10.5306/wjco.v17.i1.114238]
World J Clin Oncol. Jan 24, 2026; 17(1): 114238 Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.114238
Development and internal validation of an immune-based prognostic modeling of early-onset colorectal cancer via machine learning
Xiu Chen, Yong Wang, Heng-Yang Shen, Rui Wu, Zan Fu
Xiu Chen, Yong Wang, Heng-Yang Shen, Zan Fu, Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210029, Jiangsu Province, China
Rui Wu, Department of General Surgery, Nanjing Qixia District Hospital, Nanjing 210000, Jiangsu Province, China
Co-first authors: Xiu Chen and Yong Wang.
Author contributions: Chen X contributed to writing-original draft, formal analysis, and project administration; Chen X, Wang Y, and Wu R contributed to methodology and investigation; Chen X and Shen HY contributed to data curation; Chen X and Fu Z contributed to conceptualization; Wang Y and Fu Z contributed to R resources; Shen HY contributed to writing - review and editing; Fu Z contributed to visualization and supervision. Chen X and Wang Y contributed equally to this manuscript and are co-first authors. All authors have read and approved the final version to be published.
Supported by National Natural Science Foundation of China, No. 82172956; and Jiangsu Province Capability Improvement Project through Science, Technology and Education (Jiangsu Provincial Medical Key Discipline), No. ZDXK202222.
Institutional review board statement: The study was approved by the Ethics Committee of the First Affiliated Hospital with Nanjing Medical University (Approval No. 2023-SR-206).
Informed consent statement: All participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: Technical appendix, analytical code and dataset available from the corresponding author.
Corresponding author: Zan Fu, MD, Professor, Department of General Surgery, The First Affiliated Hospital with Nanjing Medical University, No. 300 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. fuzan1971@njmu.edu.cn
Received: September 18, 2025 Revised: October 12, 2025 Accepted: December 1, 2025 Published online: January 24, 2026 Processing time: 125 Days and 4.3 Hours
Abstract
BACKGROUND
Early-onset colorectal cancer (EOCRC) is an aggressive malignancy with rising incidence and poor prognosis in young adults. Circulating immune cells may hold prognostic value, yet their role in EOCRC outcomes remains unclear.
AIM
To develop machine learning-based prognostic models using peripheral immune markers in a retrospective cohort of EOCRC patients.
METHODS
A cohort of 123 EOCRC patients undergoing radical resection, from January 2017 to December 2020 was included. Data were extracted from medical records with a follow-up till July 2025. Blood samples were processed for flow cytometry to assess immune markers.
RESULTS
Univariable screening identified disease stage and CD16+CD56+ natural killer (NK) cell percentage as top predictors. A parsimonious Cox model integrating stage and high NK cells outperformed random survival forests (concordance index 0.693 vs 0.256). High-risk patients (stage III/IV, high NK cells) had inferior 5-year progression-free survival (61.2%; 95% confidence interval: 49.0-76.5) vs low-risk (86.4%; 95% confidence interval: 78.9-94.6; log-rank P = 0.001). Time-dependent areas under the curve ranged from 0.671 to 0.693, with robust calibration.
CONCLUSION
This two-factor model offers moderate accuracy for personalized EOCRC risk stratification, highlighting systemic NK cell dysfunction as a potential immunotherapy target. External validation is warranted.
Core Tip: Early-onset colorectal cancer (EOCRC) represents a growing public health challenge, characterized by aggressive biology and poor prognosis in young adults. While circulating immune cells play a pivotal role in cancer progression, their prognostic utility in EOCRC remains underexplored. In this study, we leveraged machine learning techniques to develop and validate a novel prognostic model integrating disease stage with peripheral CD16+CD56+ natural killer cell percentages. Our parsimonious Cox model demonstrated moderate discriminatory accuracy and clear risk stratification, with high-risk patients exhibiting significantly inferior progression-free survival. These findings highlight systemic natural killer cell dysfunction as a potential biomarker and immunotherapy target for EOCRC.
